From Cheddar.

Daniel Gilbert, Business of Medicine Reporter at The Washington Post, breaks down Novo’s first GLP-1 weight-loss pill and why it matters.

Connect with Cheddar!
On Facebook: https://facebook.com/cheddar
On Instagram: https://instagram.com/cheddar
On the web: https://cheddar.com
In your inbox: https://need2know.cheddar.com/subscribe